MoonLake Immunotherapeutics (MLTX) is around the top of the Biotechnology industry according to InvestorsObserver. MLTX received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. MoonLake Immunotherapeutics also achieved a score of 83 in the Biotechnology industry, putting it above 83 percent of Biotechnology stocks. Biotechnology is ranked 49 out of the 148 industries.
MLTX has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on MLTX!